Rare CDK12 Mutation Linked to Aggressive Inherited Prostate Cancer
Scientists have discovered a rare inherited mutation in the CDK12 gene that appears to be associated with aggressive prostate cancer. The five individuals identified with the mutation all developed metastatic disease, with diagnoses occurring between ages 44 and 62.
The finding could support expanded genetic testing for people with prostate cancer and their families. Identifying the mutation may reveal previously unrecognized cancer risks and potentially allow earlier detection, when treatment options may be more effective.
Researchers will need further evidence to determine how widely the mutation is associated with aggressive disease and how it should inform clinical testing and care.